The co-founder of Biosfer Teslab stars in the ‘Beer & Business’ cycle at El Círcol
El Círcol, founded in 1852, is a recreational cultural society based in Plaça Prim in Reus. Its current president, Patrícia Terradellas Maré, has decided to rejuvenate the social mass in order to attract new members between thirty and forty years old. Thinking of the talent that the city possesses, Patricia believes that it would be […]
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease
On April 28-29, 2021, 50 scientists from different fields of expertise met for the 3rd online CIAO workshop, in which Biosfer Teslab had the great opportunity to participate.The CIAO project “Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway (AOP) framework” aims at building a holistic assembly of the available scientific knowledge on COVID-19 using […]
Triglyceride-rich lipoproteins and glycoproteins potential biomarkers in the development of steatosis.
Recently, metabolically associated fatty liver disease (MAFLD) has become one of the leading causes of chronic liver disease worldwide, and has become a public health challenge. This disease, defined as the accumulation of fat in the liver in the presence of metabolic dysfunction, can range from simple steatosis, which involves little inflammation, to steatohepatitis characterised […]
Biosfer Teslab invited to the Biotec seminar in the framework of the second edition of the event Casa Wallonia 2021
On 24 November, the Biotec seminar “2021 the year of biotechnology” took place in Madrid as part of the second edition of the event Casa Wallonia 2021 organised by the Representation of the Walloon Region of the Belgian Embassy in Madrid at the prestigious Carlos de Amberes Foundation in Madrid. Located in the heart of […]
Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing
Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing together with 5 other start-ups in the sector organized by Telefonica Open Future. Last year, Biosfer Teslab was selected to participate in the Tarragona Open Future where it was awarded with the second place. Open […]
Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab
From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine […]
Barça Innovation Hub: Metabolomics at the forefront of elite sport
The Barça Innovation Hub (BIHUB) was created four years ago by the FC Barcelona to develop technological advances applied to sport and improve performance at the highest level. This large Barça Laboratory aims to exploit the synergy between sport and technology in order to reach the levels of demand required by the club. To work at […]
Liposcale for early and reliable diagnosis and prognosis of breast cancer patients
One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and […]
Liposcale in Circulation
Frequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small studies have shown that supplementing the diet with nuts has a considerable effect on reducing dietary cholesterol in the short term, there is little information […]
Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test
Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve […]
